Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Spero Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SPRO.
You can purchase shares of Spero Therapeutics (NASDAQ:SPRO) through any online brokerage.
Other companies in Spero Therapeutics’s space includes: Kezar Life Sciences (NASDAQ:KZR), Estrella Immunopharma (NASDAQ:ESLA), bluebird bio (NASDAQ:BLUE), Connect Biopharma Hldgs (NASDAQ:CNTB) and Aligos Therapeutics (NASDAQ:ALGS).
Spero Therapeutics has a consensus price target of $4.00.
The stock price for Spero Therapeutics (NASDAQ: SPRO) is $0.7252 last updated April 28, 2025 at 7:00 AM EDT.
A quarterly cash dividend of 0.01 per share of Class A Common Stock. The quarterly cash dividend was payable on October 7, 2015 to stockholders of record on September 16, 2015.
Spero Therapeutics’s Q1 earnings are confirmed for Wednesday, May 14, 2025.
There is no upcoming split for Spero Therapeutics.
Spero Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.